Clinical Trials Directory

Trials / Completed

CompletedNCT00624559

The Role of COX-2 Inhibition in Salt Sensitivity of Blood Pressure

COX-2 Regulation of Renal Sodium Handling in Blood Pressure Maintenance

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
12 (actual)
Sponsor
University of Delaware · Academic / Other
Sex
All
Age
22 Years – 50 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to determine if the drug Celebrex changes the way the kidney gets rid of salt and maintains blood pressure.

Detailed description

There have been many studies done with analgesics such as acetaminophen and non-steroidal anti-inflammatory drugs; however it is not understood how blood pressure changes while using Celebrex. The study hypothesis is that Celebrex will increase salt sensitivity of blood pressure.

Conditions

Interventions

TypeNameDescription
DRUGcelecoxib (Celebrex)Celecoxib (Celebrex) was administered at 100 mg, twice per day for each day of sodium diet
OTHERPlaceboPlacebo pill taken twice per day on each day of the diet

Timeline

Start date
2008-02-01
Primary completion
2009-01-01
Completion
2009-01-01
First posted
2008-02-27
Last updated
2012-01-06
Results posted
2011-12-21

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00624559. Inclusion in this directory is not an endorsement.